Lynn Dekleva, who recently took a senior role at the agency, once led an aggressive effort by industry to block regulations ...

Insmed Incorporated (NASDAQ: INSM) announced on February 24, 2025 that the U.S. Food and Drug Administration (FDA) does not ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...

Education spokeswoman Sarah Henderson said a Coalition government would impose tougher caps on international and hold a zero ...

Learn more about the new SBA administrator's top priorities, particularly efforts to empower small businesses and support the ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

By Sen. Tracy Pennycuick 24th District I heard it said recently that it’s great politics to be all things to all people.

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Cash position of €7.5 million as of December 31, 2024 BioChaperone Lispro final dosing of Phase 3 triggered a $10 million revenue recognition, and top-line data are expected in mid-2025 ...

It won’t happen until after the quarterback position is resolved. It might not transpire until late in training camp or a few ...

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...